Clinical Trial Update: Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating daratumumab after stem cell transplant in patients with multiple myeloma. The study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Multiple Myeloma

Drugs mentioned

• Daratumumab (Darzalex) (daratumumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Plasma Cell Myeloma, Secondary Amyloidosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING